Detail
Článek
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health

IM. Rivas Serna, M. Sitina, GB. Stokin, JR. Medina-Inojosa, F. Lopez-Jimenez, JP. Gonzalez-Rivas, M. Vinciguerra

. 2021 ; 11 (11) : . [pub] 20211029

Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22001425

Grantová podpora
CZ.02.1.01/0.0/0.0/16_019/0000868 European Regional Development Fund
LQ1605 National Program of Sustainability II (MEYS CR)

Ideal cardiovascular health (CVH) is defined for the presence of ideal behavioral and health metrics known to prevent cardiovascular disease (CVD). The association of circulatory phospho- and sphingo-lipids to primary reduction in cardiovascular risk is unclear. Our aim was to determine the association of CVH metrics with the circulating lipid profile of a population-based cohort. Serum sphingolipid and phospholipid species were extracted from 461 patients of the randomly selected prospective Kardiovize study based on Brno, Czech Republic. Lipids species were measured by a hyphenated mass spectrometry technique, and were associated with poor CVH scores, as defined by the American Heart Association. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE) species were significantly lower in ideal and intermediate scores of health dietary metric, blood pressure, total cholesterol and blood fasting glucose compared to poor scores. Current smokers presented higher levels of PC, PE and LPE individual species compared to non-smokers. Ceramide (Cer) d18:1/14:0 was altered in poor blood pressure, total cholesterol and fasting blood glucose metrics. Poor cardiovascular health metric is associated with a specific phospho- and sphingolipid pattern. Circulatory lipid profiling is a potential biomarker to refine cardiovascular health status in primary prevention strategies.

000      
00000naa a2200000 a 4500
001      
bmc22001425
003      
CZ-PrNML
005      
20220112153606.0
007      
ta
008      
220107s2021 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/metabo11110747 $2 doi
035    __
$a (PubMed)34822405
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Rivas Serna, Irma Magaly $u International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic
245    10
$a Lipidomic Profiling Identifies Signatures of Poor Cardiovascular Health / $c IM. Rivas Serna, M. Sitina, GB. Stokin, JR. Medina-Inojosa, F. Lopez-Jimenez, JP. Gonzalez-Rivas, M. Vinciguerra
520    9_
$a Ideal cardiovascular health (CVH) is defined for the presence of ideal behavioral and health metrics known to prevent cardiovascular disease (CVD). The association of circulatory phospho- and sphingo-lipids to primary reduction in cardiovascular risk is unclear. Our aim was to determine the association of CVH metrics with the circulating lipid profile of a population-based cohort. Serum sphingolipid and phospholipid species were extracted from 461 patients of the randomly selected prospective Kardiovize study based on Brno, Czech Republic. Lipids species were measured by a hyphenated mass spectrometry technique, and were associated with poor CVH scores, as defined by the American Heart Association. Phosphatidylcholine (PC), phosphatidylethanolamine (PE), lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE) species were significantly lower in ideal and intermediate scores of health dietary metric, blood pressure, total cholesterol and blood fasting glucose compared to poor scores. Current smokers presented higher levels of PC, PE and LPE individual species compared to non-smokers. Ceramide (Cer) d18:1/14:0 was altered in poor blood pressure, total cholesterol and fasting blood glucose metrics. Poor cardiovascular health metric is associated with a specific phospho- and sphingolipid pattern. Circulatory lipid profiling is a potential biomarker to refine cardiovascular health status in primary prevention strategies.
655    _2
$a časopisecké články $7 D016428
700    1_
$a Sitina, Michal $u International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic
700    1_
$a Stokin, Gorazd B $u International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic
700    1_
$a Medina-Inojosa, Jose R $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA $u Marriot Heart Disease Research Program, Rochester, MN 55902, USA
700    1_
$a Lopez-Jimenez, Francisco $u Division of Preventive Cardiology, Department of Cardiovascular Medicine, Mayo Clinic, Rochester, MN 55902, USA
700    1_
$a Gonzalez-Rivas, Juan P $u International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic $u Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA
700    1_
$a Vinciguerra, Manlio $u International Clinical Research Center (ICRC), St Anne's University Hospital, 53, 656 91 Brno, Czech Republic
773    0_
$w MED00193532 $t Metabolites $x 2218-1989 $g Roč. 11, č. 11 (2021)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34822405 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20220107 $b ABA008
991    __
$a 20220112153602 $b ABA008
999    __
$a ind $b bmc $g 1745475 $s 1152572
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 11 $c 11 $e 20211029 $i 2218-1989 $m Metabolites $n Metabolites $x MED00193532
GRA    __
$a CZ.02.1.01/0.0/0.0/16_019/0000868 $p European Regional Development Fund
GRA    __
$a LQ1605 $p National Program of Sustainability II (MEYS CR)
LZP    __
$a Pubmed-20220107

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...